PJPvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with PJP, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PJP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 06/15/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PJP ETF 2 | +6.97%– | +10.25%– | +8.46%– | +39.71%– | +52.22%– | +47.00%– |
| Flows | PJP ETF 2 | -$6M– | -$82M– | +$7M– | +$18M– | -$62M– | -$113M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PJP ETF 2 | +19.27%– | +16.63%– | +15.81%– | +16.19%– |
| Max drawdown | PJP ETF 2 | -4.05%– | -9.42%– | -16.11%– | -17.41%– |
| Max drawdown duration | PJP ETF 2 | 7d– | 108d– | 275d– | 788d– |
Trading data
PJP | ETF 2 | |
Last sale 6/15/2026 at 1:30 PM | $113.02 | – |
| Previous close 06/15/2026 | $113.85 | – |
| Consolidated volume 06/15/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of May 29, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PJP | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 6/15/2026 at 1:30 PM
Live
Closed
PJP | ETF 2 | |
|---|---|---|
| Last price | $113.02 | – |
| 1D performance | -0.73% | – |
| AuM | $346.98 M | – |
| E/R | 0.57% | – |
Characteristics
PJP | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | Invesco | – |
| Benchmark | Dynamic Pharmaceutical Intellidex Index | – |
| N° of holdings | 29 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2005 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
PJP
USA
94.24%
Other
5.76%
ETF 2
Sectors
PJP
Health Care
100%
Other
0%
ETF 2
Advertisement
Diversification
PJP
Total weight of top 15 holdings out of 15
62.71%
ETF 2
–
Top 15 holdings
Data as of April 30, 2026
PJP
PFIZER
5.28%
JOHNSON&JOHNSON
4.90%
MERCK & CO INC
4.76%
AMGEN-T
4.75%
GILEAD SCIENCES
4.63%
ABBVIE
4.62%
LILLY
4.46%
ABBOTT LABS
4.33%
TRAVERE THERAPEUTICS INC
3.91%
LIGAND PHARMACEUTICALS
3.79%
CORCEPT THERAPEUTICS
3.75%
UTD THERAPEUT
3.55%
JAZZ PHARMACEUTICALS
3.43%
LIQUIDIA CORPORATION
3.29%
HARMONY BIOSCIENCES HLDG
3.26%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
